The Immunosignature of Mother/Fetus Couples in Gestational Diabetes Mellitus: Role of HLA-G 14 bp ins/del and PAPP-A A/C Polymorphisms in the Uterine Inflammatory Milieu

<div>Maternal PAPP-A serum concentrations (mU/L) in the first and second trimesters of pregnancy and at delivery in controls and GDM (a). Correlation with maternal PAPP-A A/C genotypes in the first and second trimesters of pregnancy and at delivery in controls and GDM (b). Correlation with fetal PAPP-A A/C genotypes in the first and second trimesters of pregnancy and at delivery in controls and GDM (c).</div>

Disease Markers

fig4

Figure 4

Figure 4: The Immunosignature of Mother/Fetus Couples in Gestational Diabetes Mellitus: Role of HLA-G 14 bp ins/del and PAPP-A A/C Polymorphisms in the Uterine Inflammatory Milieu 

Figure 4 | The Immunosignature of Mother/Fetus Couples in Gestational Diabetes Mellitus: Role of HLA-G 14 bp ins/del and PAPP-A A/C Polymorphisms in the Uterine Inflammatory Milieu 